Cargando…

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

RATIONALE: MDMA-assisted psychotherapy is under investigation as a novel treatment for posttraumatic stress disorder (PTSD). The primary mechanism of action of MDMA involves the same reuptake transporters targeted by antidepressant medications commonly prescribed for PTSD. OBJECTIVES: Data were pool...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feduccia, Allison A., Jerome, Lisa, Mithoefer, Michael C., Holland, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826309/ https://www.ncbi.nlm.nih.gov/pubmed/33221932 http://dx.doi.org/10.1007/s00213-020-05710-w

Ejemplares similares

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
por: Jerome, Lisa, et al.
Publicado: (2020)

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
por: Feduccia, Allison A., et al.
Publicado: (2019)

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
por: Mithoefer, Michael C., et al.
Publicado: (2019)

Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder
por: Ponte, Linnae, et al.
Publicado: (2021)

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study
por: Danforth, Alicia L., et al.
Publicado: (2018)

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Gorman, Ingmar, et al.
Publicado: (2020)

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
por: Wagner, Mark T, et al.
Publicado: (2017)

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study
por: Wolfson, Philip E., et al.
Publicado: (2020)

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial
por: Monson, Candice M., et al.
Publicado: (2020)

MDMA-assisted psychotherapy for the treatment of PTSD
por: Reiff, Collin M., et al.
Publicado: (2020)

Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors in Online Drug Reviews
por: Golder, Su, et al.
Publicado: (2023)

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
por: Singleton, S. Parker, et al.
Publicado: (2023)

Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Thal, Sascha B., et al.
Publicado: (2018)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

Potential Psychiatric Uses for MDMA
por: Yazar‐Klosinski, BB, et al.
Publicado: (2017)

Psychotherapy-supported MDMA treatment for PTSD
por: Krystal, John H., et al.
Publicado: (2021)

Correction to: Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Thal, Sascha B., et al.
Publicado: (2018)

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
por: Ot’alora G, Marcela, et al.
Publicado: (2018)

The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
por: Marseille, Elliot, et al.
Publicado: (2020)

A comparison of mdma-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
por: Illingworth, B., et al.
Publicado: (2021)

MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
por: Morgan, Louise
Publicado: (2020)

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
por: Mithoefer, Michael C, et al.
Publicado: (2011)

Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD
por: Wagner, Anne C., et al.
Publicado: (2021)

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
por: Jardim, Alvaro V., et al.
Publicado: (2020)

MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
por: Stauffer, Christopher S., et al.
Publicado: (2022)

Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice
por: Collins, Helen M, et al.
Publicado: (2022)

MDMA and memory, addiction, and depression: dose-effect analysis
por: Pantoni, Madeline M., et al.
Publicado: (2022)

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems
por: Argento, Elena, et al.
Publicado: (2021)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats
por: Baarendse, Petra J. J., et al.
Publicado: (2011)

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions
por: Godes, Macha, et al.
Publicado: (2023)

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
por: Mitchell, Jennifer M., et al.
Publicado: (2021)

Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers
por: Dumont, G. J. H., et al.
Publicado: (2008)

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
por: Mithoefer, Michael C, et al.
Publicado: (2013)

MDMA for the Treatment of Negative Symptoms in Schizophrenia
por: Arnovitz, Mitchell D., et al.
Publicado: (2022)

Comparison of the neurobiological effects of attribution retraining group therapy with those of selective serotonin reuptake inhibitors
por: Wang, C., et al.
Publicado: (2013)

Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants
por: Oskotsky, Tomiko, et al.
Publicado: (2021)

Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication
por: Haijen, E., et al.
Publicado: (2017)

Efficacy and safety results from the first pivotal phase 3 randomized controlled trial of mdma-assisted psychotherapy for treatment of severe chronic PTSD
por: Van Der Kolk, B.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hlr17a0f4trlu11n8blrgfvmjo